扬州中宝药业股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
181
NMPA:181
Drug Approvals
Terbutaline Sulfate Solution for Nebulization
- Product Name
- 硫酸特布他林雾化吸入用溶液
- Approval Number
- 国药准字H20254283
- Approval Date
- May 27, 2025
NMPA
Procaterol Hydrochloride Inhalation Solution
- Product Name
- 盐酸丙卡特罗吸入溶液
- Approval Number
- 国药准字H20254362
- Approval Date
- May 27, 2025
NMPA
Polyvinyl Alcohol Eye Drops
- Product Name
- 聚乙烯醇滴眼液
- Approval Number
- 国药准字H20253595
- Approval Date
- Mar 11, 2025
NMPA
Dopamine Hydrochloride Injection
- Product Name
- 盐酸多巴胺注射液
- Approval Number
- 国药准字H20233972
- Approval Date
- Aug 1, 2023
NMPA
Lidocaine Hydrochloride Injection
- Product Name
- 盐酸利多卡因注射液
- Approval Number
- 国药准字H20233459
- Approval Date
- Jun 13, 2023
NMPA
Magnesium Sulfate Injection
- Product Name
- 硫酸镁注射液
- Approval Number
- 国药准字H20237030
- Approval Date
- Mar 15, 2023
NMPA
Aminocaproic Acid Injection
- Product Name
- 氨基己酸注射液
- Approval Number
- 国药准字H20227071
- Approval Date
- May 24, 2022
NMPA
Potassium Chloride Injection
- Product Name
- 氯化钾注射液
- Approval Number
- 国药准字H20227042
- Approval Date
- Mar 29, 2022
NMPA
Levosalbutamol Hydrochloride Nebuliser Solution
- Product Name
- 盐酸左沙丁胺醇雾化吸入溶液
- Approval Number
- 国药准字H20223048
- Approval Date
- Jan 30, 2022
NMPA
Levosalbutamol Hydrochloride Nebuliser Solution
- Product Name
- 盐酸左沙丁胺醇雾化吸入溶液
- Approval Number
- 国药准字H20223047
- Approval Date
- Jan 30, 2022
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 19
- Next
Clinical Trials
No trials found
News
No news found